AGIO Agios Pharmaceuticals33.90-1.22 (-3.5%)
Premarket Decliner
AGIO Agios Pharmaceuticals40.06+0.45+1.1%
Premarket:33.49-6.57 (-16.4%)
Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease
Globe NewswireTue, 21-Jul 7:00 AM
AGIO Agios Pharmaceuticals39.31+0.59 (+1.5%)
AGIO Agios Pharmaceuticals42.38+4.99 (+13.4%)
AGIO Agios Pharmaceuticals36.24+0.65 (+1.8%)
AGIO Agios Pharmaceuticals27.08-8.06 (-22.9%)